Compare SERV & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SERV | INMD |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | Israel |
| Employees | 380 | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 702.9M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | SERV | INMD |
|---|---|---|
| Price | $6.31 | $14.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $17.67 | $17.33 |
| AVG Volume (30 Days) | ★ 5.3M | 741.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $920.26 | $1.74 |
| Revenue Next Year | $184.90 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.78 | $12.72 |
| 52 Week High | $18.64 | $16.74 |
| Indicator | SERV | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 67.22 |
| Support Level | $5.78 | $14.58 |
| Resistance Level | $10.53 | $15.23 |
| Average True Range (ATR) | 0.45 | 0.27 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 27.06 | 81.82 |
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. The Segment derives revenue from (i) services via the Companies robot fleet, including delivery, branding and experiential services, (ii) access to software developed for the robot fleet, including certain autonomous capabilities, and (iii) access to data collected by the robot fleet, including navigation-related data. The majority of the revenue is derived from robot delivery services and food delivery platforms.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.